A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study-Reference-Cited by-同舟云学术

A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study

Published:2000-01 Issue:3-4 Volume:37 Page:367-377
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Giles Francis J.¹,Shan Jianqin¹,Chen Shanshan²,Advani Suresh H.³,Supandiman Iman⁴,Aziz Zeba⁵,Caviles Alendry P.⁶,Tee Goh Yeow⁷,Chasen Martin R.⁸,Fahed Zahira⁹,Chao Tsu-Yi¹⁰,Aydogdu Ismet¹¹,Lynott Anne M.¹

Affiliation:

1. The International Oncology Study Group, Houston, Texas, USA

2. Bejing Medical University, Beijing, PR China

3. Tata Memorial Hospital, Parel, Bombay, India

4. Hasan Sadikin Hospital, Bandung, Indonesia

5. Allama Iqbal Medical College, Lahore, Pakistan

6. Children's Medical Center, Banaue St, Quezon City, Philippines

7. Singapore General Hospital, Outram RdSingapore

8. Sandton Oncology Centre, Sandton, South Africa

9. Teshreen Military Hospital, Damascus, Syria

10. Tri-Service General Hospital, Ding-Chow Rd, Taipei, Taiwan

11. Inonu University, Malatya, Turkey